Navigation Links
Synapses recycle proteins for the release of neurotransmitters

Neurons communicate via chemical transmitters which they store in the bubble-like synaptic vesicles and release as required. To be able to react reliably to stimulation, neurons must have a certain number of "acutely releasable" vesicles. With the help of a new method, neuroscientists at the Max Planck Institute of Experimental Medicine in Gttingen have now discovered that neurons systematically recycle the protein components necessary for transmitter release and in this way guarantee the reliability of signal transmission in the brain. If this process is disrupted, the communication between the neurons quickly comes to a standstill and vital processes that rely on the rapid transmission of information, for example seeing or the instant identification of a sound source, become impossible to carry out. (Neuron, November 4, 2010)

Neurons transmit signals to each other via specialised contacts known as synapses. When a transmitting neuron is excited, it releases chemical transmitters that are discharged by tiny membrane-enclosed vesicles and then reach the recipient cell. The release of the transmitters is carried out through the fusion of the vesicles with the cell membrane - a process that requires the interaction of different protein components in the cell.

Before the transmitter vesicles can fuse with the neuronal membrane they must first be transformed into an active state. The corresponding biochemical process is referred to as priming. During this process, a structure known as a SNARE complex is constructed from protein components that are required for the rapid fusion of the vesicles with the cell membrane.

Headed by the Korean neuroscientist JeongSeop Rhee, a group of researchers from the Max Planck Institute of Experimental Medicine in Gttingen have now developed a new method that can be used for the direct measurement of synaptic vesicle priming. The scientists made use of a method that, before now, could only be used for a few special cell types. "Instead of stimulating the neurons electrically, using our measuring system we fill them with a chemically packed signal containing calcium ions and then destroy the packaging with a flash of ultraviolet light," explains Rhee. This enabled the scientists to get around many of the complicated processes that normally precede vesicle fusion. They made the process possible by cultivating neurons in Petri dishes on minute islands of just 0.04 square millimetres in size.

With his new method, Rhee and his colleagues Andrea Burgalossi and Sangyong Jung discovered that two protein components, known as SNAPs, play an extremely important role in the recycling of SNARE complexes at synapses. Without SNAPs the recovery of the individual components of SNARE complexes is blocked, and the synapse function also blocked in time.

"We are particularly fascinated by our new method," says JeongSeop Rhee, "because it provides previously unavailable insights into the mechanisms of transmitter release from synapses." The new information about the priming role of the SNAP proteins is also very important. "A number of pharmaceutical companies are working on processes to influence the priming of synaptic vesicles." If the researchers succeed in regulating this process pharmacologically, it would be possible to develop completely new epilepsy treatments that would avoid many of the side affects associated with the current treatment process.


Contact: JeongSeop Rhee

Related biology news :

1. Sponges recycle carbon to give life to coral reefs
2. A win-win: U-pick pumpkin farms recycle urban leaves
3. Breast cancer cells recycle to escape death by hormonal therapy
4. Chemists concoct new agents to easily study critical cell proteins
5. LSUHSC study IDs proteins regulating water retention in salt-sensitive hypertension
6. New clues to how cancer-related proteins plasmin, thrombin lose inhibition
7. Key difference in how TB bacteria degrade doomed proteins
8. Model unfolds proteins gently
9. Slicing proteins with Occams Razor
10. Scripps Research scientists win $65 million in new grants to reveal form and function of proteins
11. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors
Post Your Comments:
Related Image:
Synapses recycle proteins for the release of neurotransmitters
(Date:11/17/2015)... 17, 2015  Vigilant Solutions announces today that Mr. ... of Directors. --> --> ... from the partnership at TPG Capital, one of the ... $140 Billion in revenue.  He founded and led TPG,s ... TPG companies, from 1997 to 2013.  In his first ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... TEL AVIV, Israel , Nov. 24, 2015  Tikcro Technologies Ltd. ... be held on December 29, 2015 at 11:00 a.m. Israel ... & Co., Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... , election of Eric Paneth and Izhak Tamir ... and Rami Skaliter as external directors; , approval of an ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... InSphero AG, ... 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... Aregger served on the management team and was promoted to Head of ...
(Date:11/24/2015)... 24, 2015 HemoShear Therapeutics, LLC, a ... for metabolic disorders, announced today the appointment of ... of Directors (BOD). Mr. Watkins is the former ... Sciences (HGS), and also served as the chairman ... Powers , Chairman and CEO of HemoShear Therapeutics. ...
(Date:11/24/2015)... NEW YORK , Nov. 24, 2015 According ... today than in 2005. This is something that many doctors, ... long time. One questions remains: with fewer PSA tests being ... cancer ? Dr. David Samadi, "Despite ... cancer, the disease remains the second leading cancer cause of ...
Breaking Biology Technology: